Designs for phase I trials in ordered groups.

Abstract:

:We propose a new design for dose finding for cytotoxic agents in two ordered groups of patients. By ordered groups, we mean that prior to the study there is clinical information that would indicate that for a given dose one group would be more susceptible to toxicities than patients in the other group. The designs are evaluated relative to two previously proposed designs for ordered groups over a range of scenarios generated randomly from a family of dose-toxicity curves. Copyright © 2016 John Wiley & Sons, Ltd.

journal_name

Stat Med

journal_title

Statistics in medicine

authors

Conaway MR,Wages NA

doi

10.1002/sim.7133

subject

Has Abstract

pub_date

2017-01-30 00:00:00

pages

254-265

issue

2

eissn

0277-6715

issn

1097-0258

journal_volume

36

pub_type

杂志文章
  • Sam Greenhouse's years at the Census Bureau and the UNRRA.

    abstract::Sam Greenhouse joined the Census Bureau as a clerk at an interesting time period for the agency. The first use of sampling in the decennial census occurred in 1940. There was a major expansion of the amount of data collected. The organization of the Census Bureau underwent radical changes, including the growth of the ...

    journal_title:Statistics in medicine

    pub_type: 传,历史文章,杂志文章

    doi:10.1002/sim.1627

    authors: Keller J,Clark CZ

    更新日期:2003-11-15 00:00:00

  • Cutoff designs for community-based intervention studies.

    abstract::Public health interventions are often designed to target communities defined either geographically (e.g. cities, counties) or socially (e.g. schools or workplaces). The group randomized trial (GRT) is regarded as the gold standard for evaluating these interventions. However, community leaders may object to randomizati...

    journal_title:Statistics in medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/sim.4237

    authors: Pennell ML,Hade EM,Murray DM,Rhoda DA

    更新日期:2011-07-10 00:00:00

  • Design and analysis of non-inferiority mortality trials in oncology.

    abstract::The recent revision of the Declaration of Helsinki and the existence of many new therapies that affect survival or serious morbidity, and that therefore cannot be denied patients, have generated increased interest in active-control trials, particularly those intended to show equivalence or non-inferiority to the activ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.1400

    authors: Rothmann M,Li N,Chen G,Chi GY,Temple R,Tsou HH

    更新日期:2003-01-30 00:00:00

  • Weighted multiple testing correction for correlated tests.

    abstract::Virtually all clinical trials collect multiple endpoints that are usually correlated. Many methods have been proposed to control the family-wise type I error rate (FWER), but these methods often disregard the correlation among the endpoints, such as the commonly used Bonferroni correction, Holm procedure, Wiens' Bonfe...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4434

    authors: Xie C

    更新日期:2012-02-20 00:00:00

  • Multistate models and lifetime risk estimation: Application to Alzheimer's disease.

    abstract::The lifetime risk of a clinical condition is the probability of onset of the condition during one's lifespan. Recent advances in Alzheimer's disease (AD) research have identified screening tests for biomarkers that can identify persons who are in the earliest stages of the AD process but who do not yet have any clinic...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.8056

    authors: Brookmeyer R,Abdalla N

    更新日期:2019-04-30 00:00:00

  • Analyzing longitudinal data with patients in different disease states during follow-up and death as final state.

    abstract::This paper considers the analysis of longitudinal data complicated by the fact that during follow-up patients can be in different disease states, such as remission, relapse or death. If both the response of interest (for example, quality of life (QOL)) and the amount of missing data depend on this disease state, ignor...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3755

    authors: le Cessie S,de Vries EG,Buijs C,Post WJ

    更新日期:2009-12-30 00:00:00

  • Performance of analytical methods for overdispersed counts in cluster randomized trials: sample size, degree of clustering and imbalance.

    abstract::Many different methods have been proposed for the analysis of cluster randomized trials (CRTs) over the last 30 years. However, the evaluation of methods on overdispersed count data has been based mostly on the comparison of results using empiric data; i.e. when the true model parameters are not known. In this study, ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3681

    authors: Durán Pacheco G,Hattendorf J,Colford JM Jr,Mäusezahl D,Smith T

    更新日期:2009-10-30 00:00:00

  • Analysis of messy longitudinal data from a randomized clinical trial. MRC Lung Cancer Working Party.

    abstract::The randomized clinical trial, LU19, conducted by the Medical Research Council Lung Cancer Working Party, was designed to compare ACE (doxorubicin, cyclophosphamide and etoposide) chemotherapy plus G-CSF (granulocyte colony-stimulating factor) at 2-week intervals versus ACE chemotherapy alone at standard 3-week interv...

    journal_title:Statistics in medicine

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0258(20001015)19:19<2657::aid-sim557>

    authors: Qian W,Parmar MK,Sambrook RJ,Fayers PM,Girling DJ,Stephens RJ

    更新日期:2000-10-15 00:00:00

  • Predicting analysis times in randomized clinical trials.

    abstract::Randomized clinical trial designs commonly include one or more planned interim analyses. At these times an external monitoring committee reviews the accumulated data and determines whether it is scientifically and ethically appropriate for the study to continue. With failure-time endpoints, it is common to schedule an...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.843

    authors: Bagiella E,Heitjan DF

    更新日期:2001-07-30 00:00:00

  • Using orthogonal polynomial scores in summarizing and evaluating longitudinal data collected in phase I and II clinical pharmacology studies.

    abstract::Orthogonal polynomial scores (OPS) is a simple, biologically meaningful approach to characterize longitudinal data in phase I and II clinical pharmacology trials. It describes average, linear, quadratic and higher order polynomial characteristics of each subject's response over time with use of composite scores comput...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780120703

    authors: Bradstreet TE

    更新日期:1993-04-15 00:00:00

  • The many weak instruments problem and Mendelian randomization.

    abstract::Instrumental variable estimates of causal effects can be biased when using many instruments that are only weakly associated with the exposure. We describe several techniques to reduce this bias and estimate corrected standard errors. We present our findings using a simulation study and an empirical application. For th...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6358

    authors: Davies NM,von Hinke Kessler Scholder S,Farbmacher H,Burgess S,Windmeijer F,Smith GD

    更新日期:2015-02-10 00:00:00

  • An illness-death stochastic model in the analysis of longitudinal dementia data.

    abstract::A significant source of missing data in longitudinal epidemiological studies on elderly individuals is death. Subjects in large scale community-based longitudinal dementia studies are usually evaluated for disease status in study waves, not under continuous surveillance as in traditional cohort studies. Therefore, for...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.1506

    authors: Harezlak J,Gao S,Hui SL

    更新日期:2003-05-15 00:00:00

  • Exploiting relationships between outcomes in Bayesian multivariate network meta-analysis with an application to relapsing-remitting multiple sclerosis.

    abstract::In multivariate network meta-analysis (NMA), the piecemeal nature of the evidence base means that there may be treatment-outcome combinations for which no data is available. Most existing multivariate evidence synthesis models are either unable to estimate the missing treatment-outcome combinations, or can only do so ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.8668

    authors: Waddingham E,Matthews PM,Ashby D

    更新日期:2020-10-30 00:00:00

  • A Bayesian approach estimating treatment effects on biomarkers containing zeros with detection limits.

    abstract::Often in randomized clinical trials and observational studies in occupational and environmental health, a non-negative continuously distributed response variable denoting some metabolites of environmental toxicants is measured in treatment and control groups. When observations occur in both unexposed and exposed subje...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3170

    authors: Chu H,Nie L,Kensler TW

    更新日期:2008-06-15 00:00:00

  • A random set approach to confidence regions with applications to the effective dose with combinations of agents.

    abstract::The effective dose (ED) is the pharmaceutical dosage required to produce a therapeutic response in a fixed proportion of the patients. When only one drug is considered, the problem is a univariate one and has been well-studied. However, in the multidimensional setting, that is, in the presence of combinations of agent...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6226

    authors: Jankowski H,Ji X,Stanberry L

    更新日期:2014-10-30 00:00:00

  • Comparison of methods for estimating the effect of salvage therapy in prostate cancer when treatment is given by indication.

    abstract::For patients who were previously treated for prostate cancer, salvage hormone therapy is frequently given when the longitudinal marker prostate-specific antigen begins to rise during follow-up. Because the treatment is given by indication, estimating the effect of the hormone therapy is challenging. In a previous pape...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5890

    authors: Taylor JM,Shen J,Kennedy EH,Wang L,Schaubel DE

    更新日期:2014-01-30 00:00:00

  • The use of an autoregressive model for the analysis of longitudinal data in epidemiologic studies.

    abstract::Korn and Whittemore have presented methods for analyzing longitudinal data where the number of observations per individual is large relative to the number of variables considered for each subject. However, this is often not the case in epidemiologic studies, since one usually collects data at relatively few time point...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780040407

    authors: Rosner B,Muñoz A,Tager I,Speizer F,Weiss S

    更新日期:1985-10-01 00:00:00

  • Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes.

    abstract::When designing a study to develop a new prediction model with binary or time-to-event outcomes, researchers should ensure their sample size is adequate in terms of the number of participants (n) and outcome events (E) relative to the number of predictor parameters (p) considered for inclusion. We propose that the mini...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.7992

    authors: Riley RD,Snell KI,Ensor J,Burke DL,Harrell FE Jr,Moons KG,Collins GS

    更新日期:2019-03-30 00:00:00

  • A cluster model for space-time disease counts.

    abstract::Modelling disease clustering over space and time can be helpful in providing indications of possible exposures and planning corresponding public health practices. Though a considerable number of studies focus on modelling spatio-temporal patterns of disease, most of them do not directly model a spatio-temporal cluster...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.2424

    authors: Yan P,Clayton MK

    更新日期:2006-03-15 00:00:00

  • Measurement in clinical trials: a neglected issue for statisticians?

    abstract::Biostatisticians have frequently uncritically accepted the measurements provided by their medical colleagues engaged in clinical research. Such measures often involve considerable loss of information. Particularly, unfortunate is the widespread use of the so-called 'responder analysis', which may involve not only a lo...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3603

    authors: Senn S,Julious S

    更新日期:2009-11-20 00:00:00

  • Commentary: How the debate about comparative effectiveness research should impact the future of clinical trials.

    abstract::Comparative effectiveness research represents the kind of research that arguably more directly affects clinical practice and policy. It includes observational studies, clinical trials, and systematic syntheses of existing literature. In this commentary, I argue for the ongoing and critical role of randomization in com...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5400

    authors: Lauer MS

    更新日期:2012-11-10 00:00:00

  • Comparison between splines and fractional polynomials for multivariable model building with continuous covariates: a simulation study with continuous response.

    abstract::In observational studies, many continuous or categorical covariates may be related to an outcome. Various spline-based procedures or the multivariable fractional polynomial (MFP) procedure can be used to identify important variables and functional forms for continuous covariates. This is the main aim of an explanatory...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5639

    authors: Binder H,Sauerbrei W,Royston P

    更新日期:2013-06-15 00:00:00

  • Robust fitting for neuroreceptor mapping.

    abstract::Among many other uses, positron emission tomography (PET) can be used in studies to estimate the density of a neuroreceptor at each location throughout the brain by measuring the concentration of a radiotracer over time and modeling its kinetics. There are a variety of kinetic models in common usage and these typicall...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3510

    authors: Chang C,Ogden RT

    更新日期:2009-03-15 00:00:00

  • Four-fold table cell frequencies imputation in meta analysis.

    abstract::Meta analysis is a collection of quantitative methods devoted to combine summary information from related but independent studies. Because research reports usually present only data reductions and summary statistics rather than detailed data, the reviewer must often resort to rather crude methods for constructing summ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.2287

    authors: Di Pietrantonj C

    更新日期:2006-07-15 00:00:00

  • Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variables.

    abstract::Genetic markers can be used as instrumental variables, in an analogous way to randomization in a clinical trial, to estimate the causal relationship between a phenotype and an outcome variable. Our purpose is to extend the existing methods for such Mendelian randomization studies to the context of multiple genetic mar...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3843

    authors: Burgess S,Thompson SG,CRP CHD Genetics Collaboration.,Burgess S,Thompson SG,Andrews G,Samani NJ,Hall A,Whincup P,Morris R,Lawlor DA,Davey Smith G,Timpson N,Ebrahim S,Ben-Shlomo Y,Davey Smith G,Timpson N,Brown M,Ricket

    更新日期:2010-05-30 00:00:00

  • Proportional hazards models and age-period-cohort analysis of cancer rates.

    abstract::Age-period-cohort (APC) analysis is widely used in cancer epidemiology to model trends in cancer rates. We develop methods for comparative APC analysis of two independent cause-specific hazard rates assuming that an APC model holds for each one. We construct linear hypothesis tests to determine whether the two hazards...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3865

    authors: Rosenberg PS,Anderson WF

    更新日期:2010-05-20 00:00:00

  • A special case of reduced rank models for identification and modelling of time varying effects in survival analysis.

    abstract::Flexible survival models are in need when modelling data from long term follow-up studies. In many cases, the assumption of proportionality imposed by a Cox model will not be valid. Instead, a model that can identify time varying effects of fixed covariates can be used. Although there are several approaches that deal ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.7088

    authors: Perperoglou A

    更新日期:2016-12-10 00:00:00

  • Bayesian synthesis of epidemiological evidence with different combinations of exposure groups: application to a gene-gene-environment interaction.

    abstract::Meta-analysis to investigate the joint effect of multiple factors in the aetiology of a disease is of increasing importance in epidemiology. This task is often challenging in practice, because studies typically concentrate on studying the effect of only one exposure, sometimes may report the interaction between two ex...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.2689

    authors: Salanti G,Higgins JP,White IR

    更新日期:2006-12-30 00:00:00

  • Interpretation of results from subset analyses within overviews of randomized clinical trials.

    abstract::Evaluating treatment effects within different subsets of patients is a common practice in the analysis of individual randomized clinical trials. Such analyses are limited, however, by the number of patients available. Overviews, by providing evidence based on large numbers of patients, can be useful for overcoming the...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780060331

    authors: Gelber RD,Goldhirsch A

    更新日期:1987-04-01 00:00:00

  • Quantifying the impact of between-study heterogeneity in multivariate meta-analyses.

    abstract::Measures that quantify the impact of heterogeneity in univariate meta-analysis, including the very popular I(2) statistic, are now well established. Multivariate meta-analysis, where studies provide multiple outcomes that are pooled in a single analysis, is also becoming more commonly used. The question of how to quan...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5453

    authors: Jackson D,White IR,Riley RD

    更新日期:2012-12-20 00:00:00